Log in to your Inderes Free account to see all free content on this page.
Biotage
161.4
SEK
-1.28 %
BIOT
NASDAQ Stockholm
Medical Equipment & Services
Health Care
3 following
www.biotage.com/en/investor-relations-home
Biotage is active in biotechnology. The company provides solutions in chromatography, organic synthesis, and sample preparation. The company has operations on a global level, mainly concentrated in Europe, North America, and Asia, and a large part of the projects are also conducted in collaboration with other players in the said market. Customers are found in health and care, as well as in the food industry.
Revenue
1.86B
EBIT %
16.86 %
P/E
48.32
Dividend yield-%
0.99 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BIOT
Daily low / high price
160.2 / 163.4
SEK
Market cap
13.07B SEK
Turnover
8.71M SEK
Volume
54K
Latest videos
Financial calendar
Annual report
19.02.2025
General meeting
24.04.2025
Interim report
24.04.2025
Interim report
16.07.2025
Interim report
23.10.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gamma Biosciences | 16.9 % | 17.0 % |
Didner & Gerge Fonder | 7.9 % | 7.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Biotage AB (publ) Interim report January-September 2024
Biotage appoints Nomination Committee
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio